Bortezomib 2 Mg Injection 1 mg/vial, 3.5 mg/vial, 2 mg Suppliers & Bulk Manufacturers
Available Forms: Injection (lyophilized powder for solution)
Available Strengths: 1 mg/vial, 3.5 mg/vial, 2 mg
Reference Brands: Velcade® (US & EU), Bortecad (India)
Category: Oncology Cancer Care
Bortezomib Injection is a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma, available in 1 mg and 3.5 mg vials in the US and EU.
Product Description:
Bortezomib Injection, available in 1 mg and 3.5 mg lyophilized vials, is a leading oncology drug used for multiple myeloma and mantle cell lymphoma in the EU and US markets. As a proteasome inhibitor, Bortezomib disrupts protein degradation in cancer cells, inducing apoptosis and inhibiting tumor growth. Marketed under the brand Velcade®, this essential anticancer agent is available for IV and subcutaneous use. GMP-compliant manufacturers supply Bortezomib as a sterile injectable formulation, making it a high-demand product for pharmaceutical B2B sourcing, licensing, and global distribution in regulated markets.
Bortezomib 2 Mg Injection — third party manufacturing & bulk supply
Bortezomib 2 Mg Injection 1 mg/vial, 3.5 mg/vial, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Bortezomib 2 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Bortezomib 2 Mg Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Bortezomib is used for the treatment of multiple myeloma and mantle cell lymphoma. It works by inhibiting proteasomes in cancer cells, which leads to the accumulation of proteins inside the cells and ultimately helps slow down or stop the growth of cancer cells.
Bortezomib is a synthetic boronic acid–based compound developed through pharmaceutical research. It belongs to a class of medicines known as proteasome inhibitors that target specific cellular processes involved in cancer cell survival.
Common trade names include Velcade, Bortenat, Bortecad, Borviz, and other regional brands available in global markets.
Bortezomib products are manufactured by companies such as Takeda Pharmaceutical Company and Johnson & Johnson for the original brand Velcade, along with several generic manufacturers in India, Europe, and Latin America.
The generic name is Bortezomib.
Well-known brand names include Velcade (US/EU), Bortenat (India), Bortecad (India), Borviz (India), and several other generic brands available in Europe and Latin American markets.
Bortezomib is manufactured in regulated pharmaceutical facilities in countries such as the United States, India, and several European countries under strict oncology drug manufacturing and quality standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
